These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1123984)

  • 21. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative clinical study of the antihypertensive effects of urapidil versus diazoxide in patients with severe arterial hypertension].
    Gasparović V; Vrhovac B; Rumboldt Z; Ivanković D
    Lijec Vjesn; 1986; 108(11-12):494-6. PubMed ID: 3553816
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergency management of pediatric hypertension.
    Suresh S; Mahajan P; Kamat D
    Clin Pediatr (Phila); 2005; 44(9):739-45. PubMed ID: 16327960
    [No Abstract]   [Full Text] [Related]  

  • 24. Malignant hypertension. A clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors.
    Gudbrandsson T
    Acta Med Scand Suppl; 1981; 650():1-62. PubMed ID: 6948498
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.
    Cummings YE; Dillard MG
    J Natl Med Assoc; 1974 Mar; 66(2):104-7 passim. PubMed ID: 4819884
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The classification and treatment of essential hypertension using the renin-sodium index for vasoconstriction-volume analysis.
    Laragh JH
    Johns Hopkins Med J; 1975 Oct; 137(4):184-94. PubMed ID: 1185911
    [No Abstract]   [Full Text] [Related]  

  • 28. Bilateral nephrectomy: its role in management of the malignant hypertension of end-stage renal disease.
    Donohue JP; Bohnert WW; Shires DL; Bradley KP
    J Urol; 1971 Oct; 106(4):488-91. PubMed ID: 4940925
    [No Abstract]   [Full Text] [Related]  

  • 29. Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy.
    Pomerantz HZ
    Can Med Assoc J; 1968 Nov; 99(21):1043-7. PubMed ID: 5721944
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure.
    Khanna A; McCullough PA
    Rev Cardiovasc Med; 2003; 4(4):255-9. PubMed ID: 14674379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hypertension.
    Reubi E
    Clin Nephrol; 1974; 2(6):211-4. PubMed ID: 4155658
    [No Abstract]   [Full Text] [Related]  

  • 32. Return of renal function after commencing maintenance hemodialysis.
    Maxey RW; Rao TK; Manis T; Delano BG; Friedman EA
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():12-5. PubMed ID: 1232623
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating HTN crisis. How low? How fast?
    Cheng SL
    RN; 2005 Jun; 68(6):37-41; quiz 42. PubMed ID: 15991815
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of malignant hypertension.
    Dollery CT
    Mod Treat; 1966 Jan; 3(1):39-49. PubMed ID: 5904581
    [No Abstract]   [Full Text] [Related]  

  • 35. Malignant hypertension treated with modern antihypertensive drugs.
    Voudoukis IJ; Caldwell JR
    Pa Med; 1974 Jul; 77(7):43-8. PubMed ID: 4841134
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 37. Understanding malignant hypertension.
    Kincaid-Smith P
    Aust N Z J Med; 1981; 11(Suppl 1):64-8. PubMed ID: 6942804
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malignant renal arterial hypertension syndrome (clinical picture and treatment)].
    Arabidze GG; Kukharchuk VV; Abugova SP; Kutsenko AI; Kozdoba OA
    Ter Arkh; 1985; 57(6):66-8. PubMed ID: 4071417
    [No Abstract]   [Full Text] [Related]  

  • 39. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH; Resnick LM
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute arterial hypertension--causes, effects and therapy].
    Motz W; Vogt M; Strauer BE
    Klin Anasthesiol Intensivther; 1995; 47():173-80. PubMed ID: 7715173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.